Encephalitis identified as rare toxicity of immunotherapy treatment

(Vanderbilt University Medical Center) The results, published July 22 in Nature Medicine, are the latest findings by VICC researchers chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.